건강 상태

18 근거 기반 건강기능식품 연구가 있는 건강 상태

Explore health conditions with evidence-graded supplement recommendations. Each condition page ranks ingredients by the strength of clinical research supporting them.

How We Grade Evidence

각 건강 상태 페이지는 임상 근거의 강도에 따라 건강기능식품 성분의 순위를 매깁니다. 각 등급의 의미는 다음과 같습니다:

Strong Evidence

Multiple randomized controlled trials (RCTs) or meta-analyses with consistent positive results and large sample sizes.

Good Evidence

At least one RCT with mostly consistent results across studies. Evidence suggests benefit but more research may be needed.

Some Evidence

Small studies or observational data with some positive signals. Promising but insufficient for strong recommendations.

Very Early Research

In vitro studies, case reports, or pilot studies only. Early-stage research that requires clinical validation.

비만

42.4% of US adults (2023 CDC data); 650 million adults globally; prevalence has tripled since 1975

Excessive body fat (BMI ≥30) Fatigue Joint pain +4

대사증후군

34.7% of US adults (NHANES); increases with age: 50% in those >60 years

Central obesity Elevated blood pressure Elevated fasting glucose +4

코르티솔 관련 체중 증가

Chronic stress affects 75-80% of adults; cortisol-driven visceral fat accumulation is a significant component of metabolic syndrome

Abdominal weight gain Difficulty losing belly fat despite diet/exercise Sugar/carb cravings (especially evenings) +3

감정적 섭식

38-60% of overweight/obese individuals report emotional eating as a significant barrier to weight management

Eating when not physically hungry Craving specific comfort foods (high sugar/fat) Eating in response to stress/boredom/sadness +2

과체중 관리

30.7% of US adults; combined with obesity, 73.1% of US adults are overweight or obese

BMI 25-29.9 Mild fatigue Early insulin resistance +2

인슐린 저항성

40% of US adults aged 18-44 (estimated); up to 70% in obese individuals

Difficulty losing weight Carbohydrate cravings Fatigue after meals +4

갱년기 체중 증가

Affects the majority of menopausal women; average age of menopause: 51 years; 1.3 million US women enter menopause annually

Weight gain (especially abdominal) Hot flashes Sleep disruption +4

갑상선 저하 관련 체중 증가

Clinical hypothyroidism: 4.6% of US population; subclinical: 4-10% of adults; 5-8x more common in women

Weight gain (2-15 kg) Fatigue Cold intolerance +5

느린 대사

True metabolic rate 10%+ below predicted affects approximately 10-15% of the population

Difficulty losing weight despite caloric deficit Fatigue Cold intolerance +3

식욕 조절

Subjective hunger and appetite dysregulation affect the majority of individuals attempting weight loss

Persistent hunger between meals Difficulty feeling full Frequent snacking +3

체중 감량을 위한 운동 수행력

Only 23% of US adults meet both aerobic and muscle-strengthening guidelines

Low exercise tolerance Difficulty maintaining workout intensity during dieting Prolonged recovery +2

복부 지방 감소

54% of US adults have elevated waist circumference; visceral obesity increasing even among normal-weight individuals

Waist circumference >40 in (men) / >35 in (women) Elevated waist-to-hip ratio Elevated liver enzymes +2

지방 산화 촉진

Impaired fat oxidation (metabolic inflexibility) is observed in 40-60% of obese individuals

Heavy reliance on carbohydrates for energy Difficulty exercising in fasting state Metabolic inflexibility +2

체중 감량 정체기

Virtually universal — 80-95% of dieters experience a plateau within 6-12 months

Stalled weight loss despite continued caloric deficit Increased hunger Fatigue +3

체중 감량 중 근육량 유지

Universal concern during any weight loss intervention; particularly important in older adults (sarcopenic obesity)

Decreasing strength during diet Muscle soreness Fatigue +2

당 갈망

86% of people report food cravings; sugar is the most commonly craved category (especially in women)

Intense desire for sweet foods Difficulty stopping after small amounts Post-meal sugar seeking +2

위 절제 수술 후 영양 지원

~256,000 bariatric procedures performed annually in the US (2023); growing worldwide

Nutrient deficiencies Hair loss Fatigue +4

다낭성난소증후군(PCOS) 관련 체중 관리

6-12% of reproductive-age women; 60-80% of PCOS patients are overweight/obese

Weight gain (especially abdominal) Irregular periods Acne +4

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.